Invention Grant
- Patent Title: 3-sulfonyl-5-aminopyridine-2,4-diol APJ agonists
-
Application No.: US16340172Application Date: 2017-10-12
-
Publication No.: US10669258B2Publication Date: 2020-06-02
- Inventor: Jeremy M. Richter , J. Alex Bates
- Applicant: BRISTOL-MYERS SQUIBB COMPANY
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Hong Liu
- International Application: PCT/US2017/056265 WO 20171012
- International Announcement: WO2018/071622 WO 20180419
- Main IPC: C07D213/74
- IPC: C07D213/74 ; C07D401/04 ; C07D401/06 ; C07D401/14 ; C07D413/04 ; C07D413/14 ; C07D417/04 ; C07D417/14 ; C07D401/12
Abstract:
The present invention provides compounds of Formula (I) wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are APJ agonists which may be used as medicaments.
Public/Granted literature
- US20190308948A1 3-SULFONYL-5-AMINOPYRIDINE-2,4-DIOL APJ AGONISTS Public/Granted day:2019-10-10
Information query
IPC分类:
